Neural and biomarker correlates of the Parkinson's Disease-Cognitive Rating Scale in Huntington's disease
Cognitive decline is a core feature of Huntington's disease (HD), often preceding motor symptoms and progressing with disease severity. While several neuropsychological tests track cognitive changes, few studies have examined the biological correlates of brief screening tools adapted for HD. Th...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:dnet:uabarcelona_::4dc4bba39dd12a4e8e20bc7ad5bcc9bb |
| Acceso en línea: | https://ddd.uab.cat/record/326355 https://dx.doi.org/urn:doi:10.1016/j.ynirp.2025.100311 |
| Access Level: | acceso abierto |
| Palabra clave: | Huntington's disease PD-CRS Cognitive assessment MRI Neuropsychology |
| Sumario: | Cognitive decline is a core feature of Huntington's disease (HD), often preceding motor symptoms and progressing with disease severity. While several neuropsychological tests track cognitive changes, few studies have examined the biological correlates of brief screening tools adapted for HD. This study investigates the neuroanatomical and fluid biomarker correlates of performance on the Parkinson's Disease-Cognitive Rating Scale (PD-CRS), aiming to validate it as a clinically and biologically grounded tool for cognitive assessment in HD. Fifty-two symptomatic gene-expansion carriers (CAG. |
|---|